Acquired

Avadim Technologies Stock

Avadim Technologies Inc is a life sciences company.

Sign up today and learn more about Avadim Technologies Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Avadim Technologies Stock

Avadim Technologies Inc is a life sciences company that has developed a new class of life sciences solutions based on Pathogenesis Based Therapies (“PBTs”) which work to optimize the stratum corneum, integumentary functions and the associated reactive tissue. Their platform of therapies works to protect and support natural physiological functions of the outer barrier of the body, to super normalize it, supporting treatments within their three series of therapies for infection prevention, neuromuscular disorders and barrier repair. Their platform and technologies use a targeted topical delivery system, are non-toxic and are effective without the side effects of other remedy approaches. Initial acceptance in the U.S. clinical market of their first PBTs and their novel preventative approach, have shown both cost avoidance and superior effectiveness in addressing specific needs in healthcare. Avadim’s advanced therapeutic class of Pathogenesis Based Therapies is capable of unlocking pathways to address emerging gaps in global health.

Funding History

December 2014$350K
July 2015$2.3M
September 2016$917K
December 2016$580K

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo